Assessment of pan-Leishmania detection by recombinase polymerase amplification assay

Diagn Microbiol Infect Dis. 2023 Feb;105(2):115862. doi: 10.1016/j.diagmicrobio.2022.115862. Epub 2022 Nov 17.

Abstract

The spread of vector habitats along with increasing human mobility can introduce atypical Leishmania species and hence can challenge existing diagnostic practices for rapid detection of active infection with species outside the narrow target range. Here we assessed the pan-Leishmania detection ability of isothermal recombinase polymerase amplification (RPA) assays targeting 18S rRNA gene, cathepsin L-like cysteine proteinase B (Cpb) gene, and kinetoplast minicircle DNA (kDNA) regions. While the lowest limit of detection of the 18S rRNA-RPA and Cpb-RPA assays were estimated as 12 and 17 standard DNA molecules, respectively, both assays could amplify genomic DNA of 7 pathogenic Leishmania species. Evaluation of 18S rRNA-RPA and our previously developed kDNA-RPA assays on 70 real-time PCR-positive leishmaniasis samples of varying pathologies resulted in sensitivity rates of 35.71% and 88.57%, respectively, while the combined sensitivity was 98.57%. Combinatorial application of 18S rRNA-RPA and kDNA-RPA assays can be recommended for further diagnostic assessments.

Keywords: Leishmaniasis; Molecular diagnosis; Pan-Leishmania; Recombinase polymerase amplification.

MeSH terms

  • DNA, Kinetoplast / genetics
  • Humans
  • Leishmania* / genetics
  • Leishmania* / isolation & purification
  • Leishmaniasis / diagnosis
  • Nucleic Acid Amplification Techniques / methods
  • RNA, Ribosomal, 18S / genetics
  • Recombinases / genetics
  • Sensitivity and Specificity

Substances

  • DNA, Kinetoplast
  • Recombinases
  • RNA, Ribosomal, 18S